Julie Gonneaud1, Eider M Arenaza-Urquijo2, Florence Mézenge2, Brigitte Landeau2, Malo Gaubert2, Alexandre Bejanin2, Robin de Flores2, Miranka Wirth2, Clémence Tomadesso2, Géraldine Poisnel2, Ahmed Abbas2, Béatrice Desgranges2, Gaël Chételat2. 1. From Neuropsychologie et Imagerie de la Mémoire Humaine, PSL Research University, EPHE, INSERM U1077, CHU de Caen (J.G., E.M.A.-U., F.M., B.L., M.G., A.B., R.d.F., M.W., C.T., G.P., A.A., B.D., G.C.), and INSERM UMR-S U1237, GIP Cyceron (J.G., E.M.A.-U., F.M., B.L., A.B., R.d.F., C.T., G.P., G.C.), UNICAEN, Normandie University, Caen, France. gonneaud@cyceron.fr. 2. From Neuropsychologie et Imagerie de la Mémoire Humaine, PSL Research University, EPHE, INSERM U1077, CHU de Caen (J.G., E.M.A.-U., F.M., B.L., M.G., A.B., R.d.F., M.W., C.T., G.P., A.A., B.D., G.C.), and INSERM UMR-S U1237, GIP Cyceron (J.G., E.M.A.-U., F.M., B.L., A.B., R.d.F., C.T., G.P., G.C.), UNICAEN, Normandie University, Caen, France.
Abstract
OBJECTIVE: To improve our understanding of early β-amyloid (Aβ) accumulation processes using florbetapir-PET scan in 20- to 60-year-old individuals. METHODS: Seventy-six cognitively normal individuals aged 20 to 60 years, 57 cognitively normal older individuals (61-84 years old), and 70 patients with mild cognitive impairment or probable Alzheimer disease (AD) underwent a florbetapir-PET scan. Images were spatially normalized and scaled using the whole cerebellum. The relationship with age was assessed on the mean neocortical standardized uptake value ratio (SUVR) and voxelwise in the younger group to assess early Aβ accumulation processes. To compare the topography of early-age-related vs AD-related changes, Aβ increase in patients vs cognitively normal older adults was also assessed. RESULTS: A linear increase of Aβ deposition from 20 to 60 years old was found on the mean neocortical SUVR, and more specifically on the temporal neocortex. By contrast, increase in patients predominated in frontal and medial parietal areas. The temporal increase in healthy participants was still significant when including only the 20- to 50-year-old individuals and controlling for several possible methodologic confounds. CONCLUSIONS: Florbetapir binding increases linearly from 20 to 60 years old in the temporal lobe. Pending replication, including with other PET tracers, this study suggests that the well-described medial frontal and parietal accumulation in late adulthood and AD might superimpose to a physiologic accumulation of Aβ, starting from young adulthood, in temporal lobes.
OBJECTIVE: To improve our understanding of early β-amyloid (Aβ) accumulation processes using florbetapir-PET scan in 20- to 60-year-old individuals. METHODS: Seventy-six cognitively normal individuals aged 20 to 60 years, 57 cognitively normal older individuals (61-84 years old), and 70 patients with mild cognitive impairment or probable Alzheimer disease (AD) underwent a florbetapir-PET scan. Images were spatially normalized and scaled using the whole cerebellum. The relationship with age was assessed on the mean neocortical standardized uptake value ratio (SUVR) and voxelwise in the younger group to assess early Aβ accumulation processes. To compare the topography of early-age-related vs AD-related changes, Aβ increase in patients vs cognitively normal older adults was also assessed. RESULTS: A linear increase of Aβ deposition from 20 to 60 years old was found on the mean neocortical SUVR, and more specifically on the temporal neocortex. By contrast, increase in patients predominated in frontal and medial parietal areas. The temporal increase in healthy participants was still significant when including only the 20- to 50-year-old individuals and controlling for several possible methodologic confounds. CONCLUSIONS:Florbetapir binding increases linearly from 20 to 60 years old in the temporal lobe. Pending replication, including with other PET tracers, this study suggests that the well-described medial frontal and parietal accumulation in late adulthood and AD might superimpose to a physiologic accumulation of Aβ, starting from young adulthood, in temporal lobes.
Authors: David S Knopman; Emily S Lundt; Terry M Therneau; Prashanthi Vemuri; Val J Lowe; Kejal Kantarci; Jeffrey L Gunter; Matthew L Senjem; Michelle M Mielke; Mary M Machulda; Bradley F Boeve; David T Jones; Jon Graff-Radford; Sabrina M Albertson; Christopher G Schwarz; Ronald C Petersen; Clifford R Jack Journal: Brain Date: 2019-04-01 Impact factor: 13.501
Authors: Chengjie Xiong; Jingqin Luo; Folasade Agboola; Yan Li; Marilyn Albert; Sterling C Johnson; Rebecca L Koscik; Colin L Masters; Anja Soldan; Victor L Villemagne; Qiao-Xin Li; Eric M McDade; Anne M Fagan; Parinaz Massoumzadeh; Tammie Benzinger; Jason Hassenstab; Randall J Bateman; John C Morris Journal: Alzheimers Dement Date: 2019-09-07 Impact factor: 21.566
Authors: Daniel S Albrecht; Abhay Sagare; Maricarmen Pachicano; Melanie D Sweeney; Arthur Toga; Berislav Zlokovic; Helena Chui; Elizabeth Joe; Lon Schneider; John C Morris; Tammie Benzinger; Judy Pa Journal: Brain Behav Immun Date: 2021-01-22 Impact factor: 7.217
Authors: Clémence Tomadesso; Vincent de La Sayette; Robin de Flores; Pierrick Bourgeat; Victor L Villemagne; Stéphanie Egret; Francis Eustache; Gaël Chételat Journal: Alzheimers Dement (Amst) Date: 2018-03-17
Authors: Richard S Isaacson; Christine A Ganzer; Hollie Hristov; Katherine Hackett; Emily Caesar; Randy Cohen; Robert Kachko; Josefina Meléndez-Cabrero; Aneela Rahman; Olivia Scheyer; Mu Ji Hwang; Cara Berkowitz; Suzanne Hendrix; Monica Mureb; Matthew W Schelke; Lisa Mosconi; Alon Seifan; Robert Krikorian Journal: Alzheimers Dement Date: 2018-11-13 Impact factor: 21.566
Authors: Andreas Hahn; Tor O Strandberg; Erik Stomrud; Markus Nilsson; Danielle van Westen; Sebastian Palmqvist; Rik Ossenkoppele; Oskar Hansson Journal: Cereb Cortex Date: 2019-05-01 Impact factor: 5.357